Vijaylaxmi Grey

, PhD, FCACB

Professor
Pathology and Molecular Medicine

Division: Clinical Pathology

McMaster University
2N33 Health Sciences Centre
905 521-2100 ext. 76595
grey@hhsc.ca

Assistant: Charlotte Baker (ext 76439)

Education and Professional Standing

• FCACB (Fellow of Canadian Academy of Clinical Biochemistry), 1996
• PhD, University of Ottawa, 1976
• MSc, Experimental Medicine, McGill University, 1969

---

Interests

Research Focus

• Development of paedeatric age-specific reference intervals
• Part of a Canada-wide study

Clinical Focus

• Clinical focus in paediatric clinical chemistry

---

Selected Publications

• Balion, C.M., Grey, V., Ismaila, A., Blatz, S., & Seidlitz, W. (2006). Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter. BMC Pediatrics, 6, 28.
• Zavorsky, G.S., Kubow, S., Grey, V., Riverin, V., & Lands, L.C. (2007). An open label dose response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements. International Journal of Food Sciences and Nutrition, 58, 429-436.
• Grey, V., Atkinson, S. Drury, D., Casey, L., Ferland, G., Gundberg, C., & Lands, L.C. (2008). Prevalence of low bone mass and deficiencies of vitamin D and K in pediatric cystic fibrosis patients from 3 Canadian centers. Pediatrics, 122, 1014-1020.
• Drury, D., Grey, V., Ferland, G., Gundberg, C., & Lands, L.C. (2008). Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis.  Journal of Cystic Fibrosis, 7(5), 457-459.
• Eapen, E., Grey, V., Don-Wauchope, A., & Atkinson, S.A.. (2008). Bone Health in Childhood: usefulness of bone markers. eJIFCC, 19(2), 1-14.
• Rodríguez-Capote, Kim, K. Paes, B., Turner, D., Grey, V. Clinical implication of the bias between transcutaneous bilirubinometry and total serum bilirubin for the classification of newborns at risk of hyperbilirubinemia.  Clinical Biochemistry, 42(3), 176-179.